Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etretinate and visual function: a 1-year follow-up study.

J F Pitts1, R M Mackie, G N Dutton

  • 1Tennent Institute of Ophthalmology, Western Infirmary, Glasgow, U.K.

The British Journal of Dermatology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples.

The American journal on addictions·2025
Same author

Increased exposure to loading is associated with decreased plantar soft tissue hardness in people with diabetes and neuropathy.

Diabetes research and clinical practice·2022
Same author

Photodiagnostic services in the UK and Republic of Ireland: a British Photodermatology Group Workshop Report.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Negotiating boundaries of care: an interpretative phenomenological analysis of the relational conflicts surrounding home mechanical ventilation following traumatic spinal cord injury.

Health psychology and behavioral medicine·2021
Same author

The inter-relationships between cerebral visual impairment, autism and intellectual disability.

Neuroscience and biobehavioral reviews·2020
Same author

Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence.

Vox sanguinis·2018
Same journal

Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Management Patterns and Repigmentation Outcomes in Pediatric Segmental Versus Non-segmental Vitiligo: A Single-center Retrospective Study (2015-2024).

The British journal of dermatology·2026
Same journal

Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.

The British journal of dermatology·2026
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
See all related articles

Long-term etretinate treatment showed no signs of ocular toxicity in four patients. This study found no evidence of visual dysfunction despite prolonged use and high doses of the drug.

Area of Science:

  • Ophthalmology
  • Dermatology
  • Pharmacology

Background:

  • Concerns exist regarding the potential retinotoxicity of etretinate, a drug used in treating various skin conditions.
  • Previous literature has raised questions about the safety of etretinate concerning ocular health.

Purpose of the Study:

  • To evaluate the ocular safety of long-term etretinate treatment.
  • To investigate potential visual dysfunction in patients receiving etretinate therapy.

Main Methods:

  • Detailed ophthalmological evaluations were conducted over a 1-year period.
  • Four patients with a history of long-term etretinate treatment were included in the study.

Main Results:

  • No evidence of ocular toxicity was observed in any of the four patients.

Related Experiment Videos

  • Despite prolonged treatment and high cumulative doses of etretinate, no visual dysfunction was detected.

    • Conclusions:

    • Long-term etretinate therapy did not result in observable ocular toxicity in this patient cohort.
    • The findings suggest that etretinate may be safe for ocular health in patients undergoing long-term treatment.